TCI Wealth Advisors, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$8,442
+1.6%
2330.0%0.00%0.0%
Q4 2022$8,311
+3.9%
2330.0%0.00%0.0%
Q3 2022$8,000
+14.3%
2330.0%0.00%0.0%
Q2 2022$7,0000.0%233
+1.3%
0.00%0.0%
Q1 2022$7,0000.0%2300.0%0.00%0.0%
Q4 2021$7,000
+16.7%
230
+5.0%
0.00%0.0%
Q3 2021$6,0000.0%219
+21.0%
0.00%0.0%
Q2 2021$6,000
+50.0%
181
+6.5%
0.00%
-50.0%
Q1 2021$4,000
+100.0%
170
+75.3%
0.00%
+100.0%
Q4 2020$2,0000.0%970.0%0.00%0.0%
Q3 2020$2,0000.0%970.0%0.00%0.0%
Q2 2020$2,0000.0%970.0%0.00%0.0%
Q1 2020$2,000
-60.0%
97
-50.0%
0.00%
-50.0%
Q4 2019$5,000
+66.7%
194
+100.0%
0.00%
+100.0%
Q3 2019$3,0000.0%970.0%0.00%0.0%
Q2 2019$3,0000.0%970.0%0.00%0.0%
Q1 2019$3,0000.0%970.0%0.00%0.0%
Q4 2018$3,000
-50.0%
97
-11.8%
0.00%
-66.7%
Q3 2018$6,000
-25.0%
110
-17.3%
0.00%
-25.0%
Q2 2018$8,000
+100.0%
133
+37.1%
0.00%
+100.0%
Q1 2018$4,0000.0%970.0%0.00%0.0%
Q4 2017$4,0000.0%970.0%0.00%0.0%
Q3 2017$4,0000.0%970.0%0.00%0.0%
Q2 2017$4,000
+33.3%
970.0%0.00%0.0%
Q1 2017$3,000
+50.0%
970.0%0.00%
+100.0%
Q4 2016$2,000
-50.0%
97
-34.5%
0.00%
-50.0%
Q3 2016$4,000
+100.0%
148
+52.6%
0.00%
+100.0%
Q2 2016$2,000
+100.0%
970.0%0.00%0.0%
Q1 2016$1,000970.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 42,189$1,220,9500.03%
MASSMUTUAL TRUST CO FSB/ADV 320$9,2610.00%
Versant Capital Management, Inc 16$4630.00%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders